Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Antimicrobial Optimization in the ICU: Treating HABP/VABP in the Critically Ill Patient
  • CME
  • CE

Credits Available
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: May 23, 2022 Expiration: May 22, 2023
Start Activity
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SCCM and ProCE. The Society of Critical Care Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Merck Sharp & Dohme Corp.
person default
Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS
person default
Tatjana Calvano, DO, FACP, FIDSA

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe the role of rapid diagnostics in HABP/VABP caused by MDR gram-negative infections
  • Appropriately use new antimicrobial agents for both empiric and targeted therapy in MDR gram-negative HABP/VABP
  • Identify strategies for managing critically ill patients with unique clinical scenarios, such as augmented or diminished renal clearance
  • Implement effective approaches to antimicrobial stewardship and minimizing TTET

Information on this Educational Activity

Faculty

Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS

Clinical Professor
Clinical and Administrative Pharmacy
University of Georgia College of Pharmacy
Clinical Pharmacy Specialist
St. Joseph’s/Candler Health System
Savannah, Georgia

Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS, has disclosed that he has received fees for non-CME/CE services from Merck and consulting fees from Biomerieux.
Tatjana Calvano, DO, FACP, FIDSA

Program Director
Internal Medicine Residency
Madigan Army Medical Center
Joint Base Lewis
McChord, Washington

Tatjana Calvano, DO, FACP, FIDSA, has no relevant conflicts of interest to report.

Staff

Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.
Jamie Sebaaly

Director, Educational Strategy

Jamie Sebaaly, PharmD, BCPS, has no relevant conflicts of interest to report.
Jason Everly, PharmD

Director, Program Development and Educational Impact

Jason Everly, PharmD, BCOP, CHCP, has no relevant conflicts of interest to report.

Target Audience

The target audience is physicians, pharmacists, nurses, and other HCPs who care for critically ill patients with HABP/VABP.

Goal

The goal of this activity is to improve the knowledge and competence of HCPs about the diagnosis, treatment, and management of HABP/VABP in critically ill patients.

Designation Statement

The Society of Critical Care Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™.
Physicians should claim credit commensurate with the extent of their participation in the activity.

 

Nursing Continuing Education

Credit Designation

The Society of Critical Care Medicine is approved by the California Board of Registered Nursing, Provider No. 8181, for 1.0 contact hour.

Continuing Pharmacy Education

Credit Designation

The Society of Critical Care Medicine is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy credit. This symposium will provide 1.0 continuing education hour. Universal Activity Number - 0236-9999-22-060-H01.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 23, 2022, through May 22, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Antimicrobial Optimization in the ICU: Treating HABP/VABP in the Critically Ill Patient
  • CME
  • CE

Loading...
Experts discuss the pharmacist’s role in the diagnosis, treatment, and management of MDR gram-negative infections in ICU patients with HABP and VABP.
person default
Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS
person default
Tatjana Calvano, DO, FACP, FIDSA
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: May 23, 2022 Expiration: May 22, 2023

Related Content

Courtney C. Cavalieri, PharmD, BCOP Amber Draper, PharmD, BCOP Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 16, 2022 Expired: June 15, 2023

Expert webcast for pharmacists on strategies to overcome health inequities with immune checkpoint inhibitors, from Clinical Care Options (CCO)

Jessica Davis, PharmD Kamakshi V. Rao, PharmD, BCOP, FASHP Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 16, 2022 Expired: June 15, 2023

On-demand webcast from ProCE and Clinical Care Options (CCO), Rebecca Gonzalez, PharmD, BCOP, and Bhavesh Shah, RPh, BCOP, discuss the management of relapsed/refractory multiple myeloma

Rebecca Gonzalez, PharmD, BCOP Bhavesh Shah, RPh, BCOP Pharmacists: 1.5 contact hours (0.15 CEUs) Released: June 15, 2022 Expired: June 14, 2023

Expert slides for pharmacists on strategies to overcome health inequities with immune checkpoint inhibitors, from Clinical Care Options (CCO)

Jessica Davis, PharmD Kamakshi V. Rao, PharmD, BCOP, FASHP Released: June 8, 2022
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SCCM and ProCE. The Society of Critical Care Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings